15.1 Applauded the UK and France for their leadership and continued commitment to make the IFFIm a reality.
15.2 Endorsed in principle the proposal that, should there be a need for an initial disbursement of IFFIm funds early in 2005, these be spent to support the polio stockpile, measles and tetanus campaigns, and advance procurement of combination vaccines, and that most future expenditures from the IFFIm be based on the GAVI Phase II process (including strengthening immunization services).
15.3 Requested full investment cases for the polio stockpile, measles campaigns, and tetanus campaigns, to be submitted to the Board for its March/April meeting.
15.4 Agreed that the focus on introducing new vaccines cannot come at the expense of routine immunization.
15.5 Requested a comprehensive strategy to properly communicate to countries the conditionality of IFFIm in order to avoid misinterpretation.
15.6 Requested the IFFIm task team to explore whether replacement of the cold chain could be a component of the initial disbursements from the IFFIm.
15.7 Agreed that it will be the responsibility of the GAVI Board to provide public support and endorsement of the IFFIm.
15.8 Endorsed the recommendation of the IFFIm task team to recommend three candidates for the IFFIm Board at this time: Ms Jane Gladson (USA), Ms Michèle Boccoz (France), and Mr Rajiv Misra (India). Other candidates will be recommended at a later time but three directors are required now to set up the IFFIm.